37.68
Adaptiv Select Etf (ADPV) 最新ニュース
10 Funds Making the Biggest Bets on Palantir Stock - Morningstar
Form 485BPOS Series Portfolios Trust - StreetInsider.com
(ADPV) Investment Report - Stock Traders Daily
Time to Buy the Dip in Palantir Stock With These ETFs? - TradingView
Palantir’s Stock Plunge Sends Shockwaves Through ETFs – Here’s Who’s Feeling the Heat - Apna Kal
Long Term Trading Analysis for (ADPV) - Stock Traders Daily
Palantir Soars on Solid Q4 Earnings, Cautions on DeepSeek: ETFs to Buy - TradingView
Top-Performing Stock ETFs of the Month - Morningstar
Where are the Opportunities in (ADPV) - Stock Traders Daily
Palantir Nears Record Winning Streak: ETFs in Focus - MSN
(ADPV) Investment Analysis - Stock Traders Daily
ADPV: Combining Momentum And Market Timing - Seeking Alpha
100 Best Performing ETFs of 2024 - substack.com
Robinhood Agrees to $45 Million SEC Settlement Over Past Violations - Yahoo Finance
Palantir vs. NVIDIA ETFs: Better AI Plays for 2025? - Nasdaq
Palantir Vs. NVIDIA ETFs: Better AI Plays For 2025? - Barchart
Palantir Strengthens Army Partnership, Adds AI And Data Enhancements In $618.9 Million Contract - Benzinga
3 ETFs Full of Wide-Moat Stocks - Morningstar
Why Archer Aviation Stock Is Gaining Today - Benzinga
(ADPV) Technical Pivots with Risk Controls - Stock Traders Daily
How the (ADPV) price action is used to our Advantage - Stock Traders Daily
(ADPV) Trading Signals - Stock Traders Daily
(ADPV) Trading Report - Stock Traders Daily
Adicet Bio (NASDAQ:ACET) Rating Reiterated by Wedbush - MarketBeat
Adaptimmune Therapeutics Plc ADR Inc. (ADAP) Price Performance: Is It Undervalued or Overvalued? - The InvestChronicle
Adicet Bio (NASDAQ:ACET) Receives Neutral Rating from HC Wainwright - Defense World
Adicet Bio reports promising ADI-001 therapy data - Investing.com
Adicet Bio's (ACET) "Neutral" Rating Reiterated at HC Wainwright - MarketBeat
ADX: 6% Yield That Works In Few Situations (NYSE:ADX) - Seeking Alpha
Short Interest in ADC Therapeutics SA (NYSE:ADCT) Declines By 8.8% - Defense World
Recent Insider Activity Could Benefit Adaptimmune Therapeutics Plc ADR (ADAP) - Knox Daily
Mortgage Rates Drop To 2-Year Low, Refinancing Hits 'Fastest Pace' Since 2022: Rocket, LendingTree Among Movers - Benzinga
AdaptHealth Stock Earns RS Rating Upgrade - MSN
When (ADPV) Moves Investors should Listen - Stock Traders Daily
A new trading data show Adaptimmune Therapeutics Plc ADR (ADAP) is showing positive returns. - SETE News
Why Vistra and Constellation Energy Shares Are Jumping Today - Benzinga
Why Is Cloud Computing Company Nutanix's Stock Diving Thursday? - Benzinga
What's next for Palantir Technologies after its recent earnings? (NYSE:PLTR) - Seeking Alpha
Why Data Infrastructure Company Vertiv's Shares Are Rocketing Today - Benzinga
3 Great Growth ETFs for 2024 - Morningstar
How To Trade (ADPV) - Stock Traders Daily
4 Top-Rated Emerging-Markets Funds - Morningstar
Don’t Overlook Short-Term Fixed-Income Just Yet - Morningstar
Reading the Fine Print of Mid-Cap ETFs - Morningstar
Client First Enters ETF Space With Active Large-Cap ADPV - ETF Trends
CLIENT FIRST TAX & WEALTH ADVISORS ANNOUNCES NEW ADAPTIV™ SELECT ETF (TICKER: ADPV); A PROPRIETARY ACTIVELY MANAGED, LARGE CAP STOCK SELECTION ETF - PR Newswire
大文字化:
|
ボリューム (24 時間):